|
|
Confirmed Speakers
Keynote Lecture 2 - Discovery of Small Molecule mRNA Drugs and their Mechanisms of Action using Phenotypic Screening with AI-driven MOA Elucidation
 | Dr Iris ALROY
(ANIMA BIOTECH INC., Ramat Gan, Israel)
Read more
Iris Alroy, Ph.D. has 25 years of experience in drug discovery, preclinical and early clinical development. Dr. Alroy has served as CSO of Anima since 2015, supervising drug discovery and pipeline development in the emerging field of mRNA translation regulation. Prior to Anima, she acted as VP of Discovery at Proteologics and Pharmos Corp. and CEO of several startup biotech companies, including Fusimab, Ltd. and ProMining Therapeutics Ltd. Close window |
Keynote Lecture 1 - The Combined Use of Structural Biology and Biophysics at Astex for FBDD
 | Dr Marc O'REILLY
(ASTEX PHARMACEUTICALS, Cambridge, United Kingdom)
Read more
Marc O'Reilly studied physics at Imperial College (London) and completed a D.Phil in structural biology in Professor Dame Louise Johnson’s group at the Laboratory of Molecular Biophysics (Oxford) prior to taking up a post-doctoral research position at the MRC Laboratory of Molecular Biology (Cambridge, UK). Marc joined Astex Pharmaceuticals in 2000 and is currently VP, Molecular Sciences. Close window |
|
